跳至主要内容
临床试验/NCT05186714
NCT05186714已完成不适用

Mind-body Approach and Gut Microbiota in Osteoarthritis

Tufts Medical Center2 个研究点 分布在 1 个国家目标入组 72 人开始时间: 2022年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
72
试验地点
2
主要终点
Gut microbiota

研究概览

简要总结

This exploratory study is to compares mechanisms of mind-body exercise with wellness education program on gut microbiota for osteoarthritis as a basis for a future large-scale trial.

详细描述

This exploratory study is to determine the effect of mind-body exercise on gut microbiota in patients with osteoarthritis. We will randomize 80 eligible individuals who meet the American College of Rheumatology criteria for osteoarthritis into Tai Chi or wellness education interventions for 12 weeks. Using 16S rRNA amplicon sequencing of fecal DNA samples we will compare the changes in gut microbiota profiles using 16S rRNA gene amplicon sequencing, and quantity of Streptococcus species using quantitative PCR, as well as their association with clinical outcomes. This exploratory study will guide the development of theoretically informed, effective treatment for a high-risk population further enlighten us about the pathogenesis of metabolic osteoarthritis pain.This proposal will provide crucial preliminary knowledge of the mechanism underlying Tai Chi mind-body therapy for metabolic osteoarthritis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
55 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 55 years
  • Fulfills the American College of Rheumatology Criteria for symptomatic OA
  • Baseline (Month 0) WOMAC pain subscale score ≥ 40

排除标准

  • Dementia, neurological disease, cancer, cardiovascular disease, renal disease, liver disease, or other serious medical conditions limiting ability to participate in the programs.
  • Factors known or likely to impact the intestinal microbiota or known to be associated with microbial translocation: antibiotic or probiotic use within the previous 4 weeks, gastrointestinal morbidity (irritable bowel syndrome, inflammatory bowel disease, history of gastrointestinal cancer or surgical resection, or acute, severe gastrointestinal symptoms requiring medical attention), opportunistic infection, and evidence of hepatitis B or C virus infection

结局指标

主要结局

Gut microbiota

时间窗: From Week 0, to Week 12

Changes in gut composition, relative abundance and diversity, and Streptococcus abundance

次要结局

  • Change in Hospital Anxiety and Depression Scale(From Week 0 to Week 12)
  • Change in Body mass index(From Week 0 to Week 12)
  • Patient Global, 0-100 cm VAS(From Week 0 to Week 12)
  • Arthritis Self-efficacy(From Week 0 to Week 12)
  • Change in Western Ontario and McMaster University Index (WOMAC)(From Week 0 to Week 12)
  • PROMIS-29(From Week 0 to Week 12)
  • PROMIS Pain Interference(From Week 0 to Week 12)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验